Literature DB >> 23354685

MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells.

Yi Qu1, Wen-Cheng Li, Margrete Reime Hellem, Kari Rostad, Mihaela Popa, Emmet McCormack, Anne Margrete Oyan, Karl-Henning Kalland, Xi-Song Ke.   

Abstract

MicroRNAs play critical roles in tumorigenesis and metastasis. Here, we report the dual functions of miR-182 and miR-203 in our previously described prostate cell model. MiR-182 and miR-203 were completely repressed during epithelial to mesenchymal transition (EMT) from prostate epithelial EP156T cells to the progeny mesenchymal nontransformed EPT1 cells. Re-expression of miR-182 or miR-203 in EPT1 cells and prostate cancer PC3 cells induced mesenchymal to epithelial transition (MET) features. Simultaneously, miR-182 and miR-203 provided EPT1 cells with the ability to self-sufficiency of growth signals, a well-recognized oncogenic feature. Gene expression profiling showed high overlap of the genes affected by miR-182 and miR-203. SNAI2 was identified as a common target of miR-182 and miR-203. Knock-down of SNAI2 in EPT1 cells phenocopied re-expression of either miR-182 or miR-203 regarding both MET and self-sufficiency of growth signals. Strikingly, considerable overlaps of changed genes were found between the re-expression of miR-182/203 and knock-down of SNAI2. Finally, P-cadherin was identified as a direct target of SNAI2. We conclude that miR-182 and miR-203 induce MET features and growth factor independent growth via repressing SNAI2 in prostate cells. Our findings shed new light on the roles of miR-182/203 in cancer related processes.
Copyright © 2013 UICC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354685     DOI: 10.1002/ijc.28056

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

1.  MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.

Authors:  Minoru Terashima; Akihiko Ishimura; Sasithorn Wanna-Udom; Takeshi Suzuki
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

Review 2.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

3.  MicroRNA-203 inhibits cellular proliferation and invasion by targeting Bmi1 in non-small cell lung cancer.

Authors:  Tengfei Chen; Chun Xu; Jun Chen; Cheng Ding; Zhenlei Xu; Chang Li; Jun Zhao
Journal:  Oncol Lett       Date:  2015-03-27       Impact factor: 2.967

4.  Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.

Authors:  Yibing Liu; Zhiming Dong; Jia Liang; Yanli Guo; Xin Guo; Supeng Shen; Gang Kuang; Wei Guo
Journal:  Tumour Biol       Date:  2015-11-17

5.  microRNAs and Prostate Cancer.

Authors:  Sajni Josson; Leland W K Chung; Murali Gururajan
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 6.  Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.

Authors:  Valentina Doldi; Marzia Pennati; Barbara Forte; Paolo Gandellini; Nadia Zaffaroni
Journal:  Cell Mol Life Sci       Date:  2016-03-12       Impact factor: 9.261

7.  Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.

Authors:  Hiroki Imaoka; Yuji Toiyama; Masato Okigami; Hiromi Yasuda; Susumu Saigusa; Masaki Ohi; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Gastric Cancer       Date:  2015-08-02       Impact factor: 7.370

8.  Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Yoshinaga Okugawa; Shozo Ide; Hiroki Imaoka; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2015-12-23       Impact factor: 23.059

Review 9.  Regulation of mesenchymal phenotype by MicroRNAs in cancer.

Authors:  Jinchun Yan; Kiranmai Gumireddy; Anping Li; Qihong Huang
Journal:  Curr Cancer Drug Targets       Date:  2013-11       Impact factor: 3.428

10.  miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer.

Authors:  Guannan Zhao; Yuqi Guo; Zixuan Chen; Yinan Wang; Chuanhe Yang; Andrew Dudas; Ziyun Du; Wen Liu; Yanan Zou; Erzsebet Szabo; Sue-Chin Lee; Michelle Sims; Weiwang Gu; Todd Tillmanns; Lawrence M Pfeffer; Gabor Tigyi; Junming Yue
Journal:  J Cancer Sci Ther       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.